0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Blood Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-19L4050
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artificial Blood Market Insights and Forecast to 2028
BUY CHAPTERS

Global Artificial Blood Market Research Report 2025

Code: QYRE-Auto-19L4050
Report
August 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Blood Market Size

The global market for Artificial Blood was valued at US$ 3871 million in the year 2024 and is projected to reach a revised size of US$ 8259 million by 2031, growing at a CAGR of 11.6% during the forecast period.

Artificial Blood Market

Artificial Blood Market

Artificial blood, also known as synthetic blood or blood substitute, refers to a substance designed to mimic the oxygen-carrying properties of natural blood. It is used in medical emergencies when natural blood is unavailable.
The development of safe and effective artificial blood is an ongoing area of research. It has the potential to address critical shortages in blood supply for medical transfusions.
This report aims to provide a comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood.
The Artificial Blood market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Artificial Blood Market Report

Report Metric Details
Report Name Artificial Blood Market
Accounted market size in year US$ 3871 million
Forecasted market size in 2031 US$ 8259 million
CAGR 11.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hemoglobin-Based Oxygen Carriers (HBOCs)
  • Perflurocarbon Emulsions (PFCEs)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Artificial Blood company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Artificial Blood Market growing?

Ans: The Artificial Blood Market witnessing a CAGR of 11.6% during the forecast period 2025-2031.

What is the Artificial Blood Market size in 2031?

Ans: The Artificial Blood Market size in 2031 will be US$ 8259 million.

Who are the main players in the Artificial Blood Market report?

Ans: The main players in the Artificial Blood Market are Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma

What are the Application segmentation covered in the Artificial Blood Market report?

Ans: The Applications covered in the Artificial Blood Market report are Hemoglobin-Based Oxygen Carriers (HBOCs), Perflurocarbon Emulsions (PFCEs)

What are the Type segmentation covered in the Artificial Blood Market report?

Ans: The Types covered in the Artificial Blood Market report are Human Blood, Synthetic Blood, Animal Blood

Recommended Reports

Artificial Blood Solutions

Blood Collection Devices

Blood Purification Tech

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Blood Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human Blood
1.2.3 Synthetic Blood
1.2.4 Animal Blood
1.3 Market by Application
1.3.1 Global Artificial Blood Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
1.3.3 Perflurocarbon Emulsions (PFCEs)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Blood Market Perspective (2020-2031)
2.2 Global Artificial Blood Growth Trends by Region
2.2.1 Global Artificial Blood Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Blood Historic Market Size by Region (2020-2025)
2.2.3 Artificial Blood Forecasted Market Size by Region (2026-2031)
2.3 Artificial Blood Market Dynamics
2.3.1 Artificial Blood Industry Trends
2.3.2 Artificial Blood Market Drivers
2.3.3 Artificial Blood Market Challenges
2.3.4 Artificial Blood Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Blood Players by Revenue
3.1.1 Global Top Artificial Blood Players by Revenue (2020-2025)
3.1.2 Global Artificial Blood Revenue Market Share by Players (2020-2025)
3.2 Global Artificial Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Blood Revenue
3.4 Global Artificial Blood Market Concentration Ratio
3.4.1 Global Artificial Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Blood Revenue in 2024
3.5 Global Key Players of Artificial Blood Head office and Area Served
3.6 Global Key Players of Artificial Blood, Product and Application
3.7 Global Key Players of Artificial Blood, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Blood Breakdown Data by Type
4.1 Global Artificial Blood Historic Market Size by Type (2020-2025)
4.2 Global Artificial Blood Forecasted Market Size by Type (2026-2031)
5 Artificial Blood Breakdown Data by Application
5.1 Global Artificial Blood Historic Market Size by Application (2020-2025)
5.2 Global Artificial Blood Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Blood Market Size (2020-2031)
6.2 North America Artificial Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Blood Market Size by Country (2020-2025)
6.4 North America Artificial Blood Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Blood Market Size (2020-2031)
7.2 Europe Artificial Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Blood Market Size by Country (2020-2025)
7.4 Europe Artificial Blood Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Blood Market Size (2020-2031)
8.2 Asia-Pacific Artificial Blood Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Blood Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Blood Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Blood Market Size (2020-2031)
9.2 Latin America Artificial Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Blood Market Size by Country (2020-2025)
9.4 Latin America Artificial Blood Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Blood Market Size (2020-2031)
10.2 Middle East & Africa Artificial Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Blood Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Blood Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Company Details
11.1.2 Aurum Biosciences Ltd. Business Overview
11.1.3 Aurum Biosciences Ltd. Artificial Blood Introduction
11.1.4 Aurum Biosciences Ltd. Revenue in Artificial Blood Business (2020-2025)
11.1.5 Aurum Biosciences Ltd. Recent Development
11.2 HEMARINA SA
11.2.1 HEMARINA SA Company Details
11.2.2 HEMARINA SA Business Overview
11.2.3 HEMARINA SA Artificial Blood Introduction
11.2.4 HEMARINA SA Revenue in Artificial Blood Business (2020-2025)
11.2.5 HEMARINA SA Recent Development
11.3 HbO2 Therapeutics
11.3.1 HbO2 Therapeutics Company Details
11.3.2 HbO2 Therapeutics Business Overview
11.3.3 HbO2 Therapeutics Artificial Blood Introduction
11.3.4 HbO2 Therapeutics Revenue in Artificial Blood Business (2020-2025)
11.3.5 HbO2 Therapeutics Recent Development
11.4 KaloCyte Inc.
11.4.1 KaloCyte Inc. Company Details
11.4.2 KaloCyte Inc. Business Overview
11.4.3 KaloCyte Inc. Artificial Blood Introduction
11.4.4 KaloCyte Inc. Revenue in Artificial Blood Business (2020-2025)
11.4.5 KaloCyte Inc. Recent Development
11.5 SpheriTech Ltd.
11.5.1 SpheriTech Ltd. Company Details
11.5.2 SpheriTech Ltd. Business Overview
11.5.3 SpheriTech Ltd. Artificial Blood Introduction
11.5.4 SpheriTech Ltd. Revenue in Artificial Blood Business (2020-2025)
11.5.5 SpheriTech Ltd. Recent Development
11.6 NuvOx Pharma
11.6.1 NuvOx Pharma Company Details
11.6.2 NuvOx Pharma Business Overview
11.6.3 NuvOx Pharma Artificial Blood Introduction
11.6.4 NuvOx Pharma Revenue in Artificial Blood Business (2020-2025)
11.6.5 NuvOx Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Artificial Blood Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Human Blood
 Table 3. Key Players of Synthetic Blood
 Table 4. Key Players of Animal Blood
 Table 5. Global Artificial Blood Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Artificial Blood Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Artificial Blood Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Artificial Blood Market Share by Region (2020-2025)
 Table 9. Global Artificial Blood Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Artificial Blood Market Share by Region (2026-2031)
 Table 11. Artificial Blood Market Trends
 Table 12. Artificial Blood Market Drivers
 Table 13. Artificial Blood Market Challenges
 Table 14. Artificial Blood Market Restraints
 Table 15. Global Artificial Blood Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Artificial Blood Market Share by Players (2020-2025)
 Table 17. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2024)
 Table 18. Ranking of Global Top Artificial Blood Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Artificial Blood Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Artificial Blood, Headquarters and Area Served
 Table 21. Global Key Players of Artificial Blood, Product and Application
 Table 22. Global Key Players of Artificial Blood, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Artificial Blood Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Artificial Blood Revenue Market Share by Type (2020-2025)
 Table 26. Global Artificial Blood Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Artificial Blood Revenue Market Share by Type (2026-2031)
 Table 28. Global Artificial Blood Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Artificial Blood Revenue Market Share by Application (2020-2025)
 Table 30. Global Artificial Blood Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Artificial Blood Revenue Market Share by Application (2026-2031)
 Table 32. North America Artificial Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Artificial Blood Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Artificial Blood Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Artificial Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Artificial Blood Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Artificial Blood Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Artificial Blood Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Artificial Blood Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Artificial Blood Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Artificial Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Artificial Blood Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Artificial Blood Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Artificial Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Artificial Blood Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Artificial Blood Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Aurum Biosciences Ltd. Company Details
 Table 48. Aurum Biosciences Ltd. Business Overview
 Table 49. Aurum Biosciences Ltd. Artificial Blood Product
 Table 50. Aurum Biosciences Ltd. Revenue in Artificial Blood Business (2020-2025) & (US$ Million)
 Table 51. Aurum Biosciences Ltd. Recent Development
 Table 52. HEMARINA SA Company Details
 Table 53. HEMARINA SA Business Overview
 Table 54. HEMARINA SA Artificial Blood Product
 Table 55. HEMARINA SA Revenue in Artificial Blood Business (2020-2025) & (US$ Million)
 Table 56. HEMARINA SA Recent Development
 Table 57. HbO2 Therapeutics Company Details
 Table 58. HbO2 Therapeutics Business Overview
 Table 59. HbO2 Therapeutics Artificial Blood Product
 Table 60. HbO2 Therapeutics Revenue in Artificial Blood Business (2020-2025) & (US$ Million)
 Table 61. HbO2 Therapeutics Recent Development
 Table 62. KaloCyte Inc. Company Details
 Table 63. KaloCyte Inc. Business Overview
 Table 64. KaloCyte Inc. Artificial Blood Product
 Table 65. KaloCyte Inc. Revenue in Artificial Blood Business (2020-2025) & (US$ Million)
 Table 66. KaloCyte Inc. Recent Development
 Table 67. SpheriTech Ltd. Company Details
 Table 68. SpheriTech Ltd. Business Overview
 Table 69. SpheriTech Ltd. Artificial Blood Product
 Table 70. SpheriTech Ltd. Revenue in Artificial Blood Business (2020-2025) & (US$ Million)
 Table 71. SpheriTech Ltd. Recent Development
 Table 72. NuvOx Pharma Company Details
 Table 73. NuvOx Pharma Business Overview
 Table 74. NuvOx Pharma Artificial Blood Product
 Table 75. NuvOx Pharma Revenue in Artificial Blood Business (2020-2025) & (US$ Million)
 Table 76. NuvOx Pharma Recent Development
 Table 77. Research Programs/Design for This Report
 Table 78. Key Data Information from Secondary Sources
 Table 79. Key Data Information from Primary Sources
 Table 80. Authors List of This Report


List of Figures
 Figure 1. Artificial Blood Picture
 Figure 2. Global Artificial Blood Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Artificial Blood Market Share by Type: 2024 VS 2031
 Figure 4. Human Blood Features
 Figure 5. Synthetic Blood Features
 Figure 6. Animal Blood Features
 Figure 7. Global Artificial Blood Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Artificial Blood Market Share by Application: 2024 VS 2031
 Figure 9. Hemoglobin-Based Oxygen Carriers (HBOCs) Case Studies
 Figure 10. Perflurocarbon Emulsions (PFCEs) Case Studies
 Figure 11. Artificial Blood Report Years Considered
 Figure 12. Global Artificial Blood Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Artificial Blood Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Artificial Blood Market Share by Region: 2024 VS 2031
 Figure 15. Global Artificial Blood Market Share by Players in 2024
 Figure 16. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Artificial Blood Revenue in 2024
 Figure 18. North America Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Artificial Blood Market Share by Country (2020-2031)
 Figure 20. United States Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Artificial Blood Market Share by Country (2020-2031)
 Figure 24. Germany Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Artificial Blood Market Share by Region (2020-2031)
 Figure 32. China Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Artificial Blood Market Share by Country (2020-2031)
 Figure 40. Mexico Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Artificial Blood Market Share by Country (2020-2031)
 Figure 44. Turkey Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Artificial Blood Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Aurum Biosciences Ltd. Revenue Growth Rate in Artificial Blood Business (2020-2025)
 Figure 48. HEMARINA SA Revenue Growth Rate in Artificial Blood Business (2020-2025)
 Figure 49. HbO2 Therapeutics Revenue Growth Rate in Artificial Blood Business (2020-2025)
 Figure 50. KaloCyte Inc. Revenue Growth Rate in Artificial Blood Business (2020-2025)
 Figure 51. SpheriTech Ltd. Revenue Growth Rate in Artificial Blood Business (2020-2025)
 Figure 52. NuvOx Pharma Revenue Growth Rate in Artificial Blood Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS